Prostate Cancer in 2024: Recent Updates and Treatment Advances

Prostate Cancer in 2024: Recent Updates and Treatment Advances
Session moderated by Bob Wachter

Several recent scientific advances have revolutionized treatment for prostate cancer, the most common non-skin cancer in American men. Unfortunately, many patients develop treatment resistance through androgen receptor mutations and other forms of molecular trickery. In this Medical Grand Rounds, we will explore recent therapeutic advances, including imaging techniques and novel immunotherapies, dive into resistance mechanisms, and discuss promising new options for managing resistant cases and enhancing survival rates.

Speaker:
Rahul Aggarwal, MD, is the Thomas Perkins Distinguished Professor of Cancer Research and a medical oncologist in the Division of Hematology and Oncology at UCSF Health. He is the director of the UCSF Genitourinary Medical Oncology Program and associate director of clinical research in the UCSF Helen Diller Family Comprehensive Cancer Center. His clinical practice focuses on patients with genitourinary malignancies including prostate, kidney, bladder, and testicular cancer, while his research develops novel therapies and imaging modalities for patients with advanced prostate cancer.
 

How to Attend

In Person:
S-214 (Medical Sciences Building) 
Lunch will be provided

On Zoom:
Join from a PC, Mac, iPad, iPhone or Android device:
https://ucsf.zoom.us/j/97645766587?pwd=OpxbkAwpMENJgLN8xpPHofjwzHD8JH.1
Webinar ID: 976 4576 6587
Passcode: 364678

By Phone (for higher quality, dial a number based on your current location):
US: +1 669 900 6833 or +1 213 338 8477 or +1 669 219 2599
International numbers available: https://ucsf.zoom.us/u/abt1xcyvsc

The session will be recorded for later play. See all past recordings.